title: Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy.
authors.affiliation: Division of Endocrinology, Diabetes, and Nutrition and Program in Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
authors.forename: J P
authors.initials: JP
authors.lastname: Lewis
authors.forename: L M
authors.initials: LM
authors.lastname: Yerges-Armstrong
authors.forename: S
authors.initials: S
authors.lastname: Ellero-Simatos
authors.forename: A
authors.initials: A
authors.lastname: Georgiades
authors.forename: R
authors.initials: R
authors.lastname: Kaddurah-Daouk
authors.forename: T
authors.initials: T
authors.lastname: Hankemeier
mesh_terms: D001241:Aspirin / Q000378:metabolism / Q000494:pharmacology; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D055432:Metabolomics / Q000379:methods*; D010597:Pharmacogenetics / Q000379:methods*; D010974:Platelet Aggregation / Q000187:drug effects / Q000235:genetics; D010975:Platelet Aggregation Inhibitors / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
references.citation: Clin Pharmacol Ther. 2011 Jan;89(1):97-104
references.pmid: 21107318
references.citation: Pharmacogenet Genomics. 2012 Apr;22(4):247-53
references.pmid: 22322242
references.citation: Am Heart J. 2008 May;155(5):823-8
references.pmid: 18440328
references.citation: Clin Pharmacol Ther. 2013 Oct;94(4):525-32
references.pmid: 23839601
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5292-7
references.pmid: 10220459